Europe Sorafenib Market Research Report Forecast 2017 to 2022

November 2017 | 134 pages | ID: E9E74662E7EEN
S&P Consulting

Abstracts

Delivery of the Report will take 2-3 working days once order is placed.

The Europe Sorafenib Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the Sorafenib industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Sorafenib market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

Europe Sorafenib Market Analysis by Countries:
Germany
France
UK
Russia
Italy
Spain
Benelux

The Major players reported in the market include:
Pfizer
Allergan
Alnylam Pharmaceuticals
Amgen
Angstrom Pharmaceuticals
Acceleron Pharma
Biocon
Bionomics
CASI Pharmaceuticals

Europe Sorafenib Market Analysis by Product:
Type 1
Type 2
Type 3

Europe Sorafenib Market Analysis by Application:
Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

1 SORAFENIB MARKET OVERVIEW

1.1 Product Overview and Scope of Sorafenib
1.2 Classification of Sorafenib
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Sorafenib
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Sorafenib Market States Status and Prospect (2012-2022) by Countries
  1.4.1 Germany
  1.4.2 France
  1.4.3 UK
  1.4.4 Russia
  1.4.5 Italy
  1.4.6 Spain
  1.4.7 Benelux
1.5 Europe Market Size (Value and Volume) of Sorafenib (2012-2022)
  1.5.1 Europe Sorafenib Sales and Growth Rate (2012-2022)
  1.5.2 Europe Sorafenib Revenue and Growth Rate (2012-2022)

2 EUROPE ECONOMIC IMPACT ON SORAFENIB INDUSTRY

2.1 Europe Macroeconomic Analysis
2.2 Europe Macroeconomic Environment Development Trend

3 SORAFENIB MANUFACTURING COST ANALYSIS

3.1 Sorafenib Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Sorafenib

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Sorafenib Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Sorafenib Major Manufacturers in 2016
4.4 Downstream Buyers

5 EUROPE SORAFENIB MARKET ANALYSIS BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Europe Sorafenib Market Competition by Manufacturers
  5.1.1 Europe Sorafenib Sales and Market Share of Key Manufacturers (2015 and 2016)
  5.1.2 Europe Sorafenib Revenue and Share by Manufacturers (2015 and 2016)
5.2 Europe Sorafenib (Volume and Value) by Type
  5.2.1 Europe Sorafenib Sales and Market Share by Type (2012-2017)
  5.2.2 Europe Sorafenib Revenue and Market Share by Type (2012-2017)
5.3 Europe Sorafenib (Volume and Value) by Countries
  5.3.1 Europe Sorafenib Sales and Market Share by Countries (2012-2017)
  5.3.2 Europe Sorafenib Revenue and Market Share by Countries (2012-2017)
5.4 Europe Sorafenib (Volume) by Application

6 GERMANY SORAFENIB (VOLUME, VALUE AND SALES PRICE)

6.1 Germany Sorafenib Sales and Value (2012-2017)
  6.1.1 Germany Sorafenib Sales and Growth Rate (2012-2017)
  6.1.2 Germany Sorafenib Revenue and Growth Rate (2012-2017)
  6.1.3 Germany Sorafenib Sales Price Trend (2012-2017)
6.2 Germany Sorafenib Sales and Market Share by Manufacturers
6.3 Germany Sorafenib Sales and Market Share by Type
6.4 Germany Sorafenib Sales and Market Share by Application

7 FRANCE SORAFENIB (VOLUME, VALUE AND SALES PRICE)

7.1 France Sorafenib Sales and Value (2012-2017)
  7.1.1 France Sorafenib Sales and Growth Rate (2012-2017)
  7.1.2 France Sorafenib Revenue and Growth Rate (2012-2017)
  7.1.3 France Sorafenib Sales Price Trend (2012-2017)
7.2 France Sorafenib Sales and Market Share by Manufacturers
7.3 France Sorafenib Sales and Market Share by Type
7.4 France Sorafenib Sales and Market Share by Application

8 UK SORAFENIB (VOLUME, VALUE AND SALES PRICE)

8.1 UK Sorafenib Sales and Value (2012-2017)
  8.1.1 UK Sorafenib Sales and Growth Rate (2012-2017)
  8.1.2 UK Sorafenib Revenue and Growth Rate (2012-2017)
  8.1.3 UK Sorafenib Sales Price Trend (2012-2017)
8.2 UK Sorafenib Sales and Market Share by Manufacturers
8.3 UK Sorafenib Sales and Market Share by Type
8.4 UK Sorafenib Sales and Market Share by Application

9 RUSSIA SORAFENIB (VOLUME, VALUE AND SALES PRICE)

9.1 Russia Sorafenib Sales and Value (2012-2017)
  9.1.1 Russia Sorafenib Sales and Growth Rate (2012-2017)
  9.1.2 Russia Sorafenib Revenue and Growth Rate (2012-2017)
  9.1.3 Russia Sorafenib Sales Price Trend (2012-2017)
9.2 Russia Sorafenib Sales and Market Share by Manufacturers
9.3 Russia Sorafenib Sales and Market Share by Type
9.4 Russia Sorafenib Sales and Market Share by Application

10 ITALY SORAFENIB (VOLUME, VALUE AND SALES PRICE)

10.1 Italy Sorafenib Sales and Value (2012-2017)
  10.1.1 Italy Sorafenib Sales and Growth Rate (2012-2017)
  10.1.2 Italy Sorafenib Revenue and Growth Rate (2012-2017)
  10.1.3 Italy Sorafenib Sales Price Trend (2012-2017)
10.2 Italy Sorafenib Sales and Market Share by Manufacturers
10.3 Italy Sorafenib Sales and Market Share by Type
10.4 Italy Sorafenib Sales and Market Share by Application

11 SPAIN SORAFENIB (VOLUME, VALUE AND SALES PRICE)

11.1 Spain Sorafenib Sales and Value (2012-2017)
  11.1.1 Spain Sorafenib Sales and Growth Rate (2012-2017)
  11.1.2 Spain Sorafenib Revenue and Growth Rate (2012-2017)
  11.1.3 Spain Sorafenib Sales Price Trend (2012-2017)
11.2 Spain Sorafenib Sales and Market Share by Manufacturers
11.3 Spain Sorafenib Sales and Market Share by Type
11.4 Spain Sorafenib Sales and Market Share by Application

12 BENELUX SORAFENIB (VOLUME, VALUE AND SALES PRICE)

12.1 Benelux Sorafenib Sales and Value (2012-2017)
  12.1.1 Benelux Sorafenib Sales and Growth Rate (2012-2017)
  12.1.2 Benelux Sorafenib Revenue and Growth Rate (2012-2017)
  12.1.3 Benelux Sorafenib Sales Price Trend (2012-2017)
12.2 Benelux Sorafenib Sales and Market Share by Manufacturers
12.3 Benelux Sorafenib Sales and Market Share by Type
12.4 Benelux Sorafenib Sales and Market Share by Application

13 EUROPE SORAFENIB MANUFACTURERS ANALYSIS

13.1 Pfizer
  13.1.1 Company Basic Information, Manufacturing Base and Competitors
  13.1.2 Product Type, Application and Specification
  13.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.1.4 Business Overview
13.2 Allergan
  13.2.1 Company Basic Information, Manufacturing Base and Competitors
  13.2.2 Product Type, Application and Specification
  13.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.2.4 Business Overview
13.3 Alnylam Pharmaceuticals
  13.3.1 Company Basic Information, Manufacturing Base and Competitors
  13.3.2 Product Type, Application and Specification
  13.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.3.4 Business Overview
13.4 Amgen
  13.4.1 Company Basic Information, Manufacturing Base and Competitors
  13.4.2 Product Type, Application and Specification
  13.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.4.4 Business Overview
13.5 Angstrom Pharmaceuticals
  13.5.1 Company Basic Information, Manufacturing Base and Competitors
  13.5.2 Product Type, Application and Specification
  13.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.5.4 Business Overview
13.6 Acceleron Pharma
  13.6.1 Company Basic Information, Manufacturing Base and Competitors
  13.6.2 Product Type, Application and Specification
  13.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.6.4 Business Overview
13.7 Biocon
  13.7.1 Company Basic Information, Manufacturing Base and Competitors
  13.7.2 Product Type, Application and Specification
  13.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.7.4 Business Overview
13.8 Bionomics
  13.8.1 Company Basic Information, Manufacturing Base and Competitors
  13.8.2 Product Type, Application and Specification
  13.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.8.4 Business Overview
13.9 CASI Pharmaceuticals
  13.9.1 Company Basic Information, Manufacturing Base and Competitors
  13.9.2 Product Type, Application and Specification
  13.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.9.4 Business Overview

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 EUROPE SORAFENIB MARKET FORECAST (2017-2022)

15.1 Germany Market Forecast (2017-2022)
15.2 France Market Forecast (2017-2022)
15.3 UK Market Forecast (2017-2022)
15.4 Russia Market Forecast (2017-2022)
15.5 Italy Market Forecast (2017-2022)
15.6 Spain Market Forecast (2017-2022)
15.7 Benelux Market Forecast (2017-2022)
15.8 Europe Sorafenib Market Forecast by Type (2017-2022)
15.9 Europe Sorafenib Market Forecast by Application (2017-2022)

16 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Sorafenib
Table Classification of Sorafenib
Figure Europe Sales Market Share of Sorafenib by Type in 2016
Table Application of Sorafenib
Figure Europe Sales Market Share of Sorafenib by Application in 2016
Figure Germany Sorafenib Revenue and Growth Rate (2012-2022)
Figure France Sorafenib Revenue and Growth Rate (2012-2022)
Figure UK Sorafenib Revenue and Growth Rate (2012-2022)
Figure Russia Sorafenib Revenue and Growth Rate (2012-2022)
Figure Italy Sorafenib Revenue and Growth Rate (2012-2022)
Figure Spain Sorafenib Revenue and Growth Rate (2012-2022)
Figure Benelux Sorafenib Revenue and Growth Rate (2012-2022)
Figure Europe Sorafenib Sales and Growth Rate (2012-2022)
Figure Europe Sorafenib Revenue and Growth Rate (2012-2022)
Table Europe Sorafenib Sales of Key Manufacturers (2015 and 2016)
Table Europe Sorafenib Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Sorafenib Sales Share by Manufacturers
Figure 2016 Sorafenib Sales Share by Manufacturers
Table Europe Sorafenib Revenue by Manufacturers (2015 and 2016)
Table Europe Sorafenib Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Sorafenib Revenue Share by Manufacturers
Table 2016 Europe Sorafenib Revenue Share by Manufacturers
Table Europe Sorafenib Sales and Market Share by Type (2012-2017)
Table Europe Sorafenib Sales Share by Type (2012-2017)
Figure Sales Market Share of Sorafenib by Type (2012-2017)
Figure Europe Sorafenib Sales Growth Rate by Type (2012-2017)
Table Europe Sorafenib Revenue and Market Share by Type (2012-2017)
Table Europe Sorafenib Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Sorafenib by Type (2012-2017)
Figure Europe Sorafenib Revenue Growth Rate by Type (2012-2017)
Table Europe Sorafenib Sales and Market Share by Countries (2012-2017)
Table Europe Sorafenib Sales Share by Countries (2012-2017)
Figure Sales Market Share of Sorafenib by Countries (2012-2017)
Table Europe Sorafenib Revenue and Market Share by Countries (2012-2017)
Table Europe Sorafenib Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Sorafenib by Countries (2012-2017)
Table Europe Sorafenib Sales and Market Share by Application (2012-2017)
Table Europe Sorafenib Sales Share by Application (2012-2017)
Figure Sales Market Share of Sorafenib by Application (2012-2017)
Figure Germany Sorafenib Sales and Growth Rate (2012-2017)
Figure Germany Sorafenib Revenue and Growth Rate (2012-2017)
Figure Germany Sorafenib Sales Price Trend (2012-2017)
Table Germany Sorafenib Sales by Manufacturers (2015 and 2016)
Table Germany Sorafenib Market Share by Manufacturers (2015 and 2016)
Table Germany Sorafenib Sales by Type (2015 and 2016)
Table Germany Sorafenib Market Share by Type (2015 and 2016)
Table Germany Sorafenib Sales by Application (2015 and 2016)
Table Germany Sorafenib Market Share by Application (2015 and 2016)
Figure France Sorafenib Sales and Growth Rate (2012-2017)
Figure France Sorafenib Revenue and Growth Rate (2012-2017)
Figure France Sorafenib Sales Price Trend (2012-2017)
Table France Sorafenib Sales by Manufacturers (2015 and 2016)
Table France Sorafenib Market Share by Manufacturers (2015 and 2016)
Table France Sorafenib Sales by Type (2015 and 2016)
Table France Sorafenib Market Share by Type (2015 and 2016)
Table France Sorafenib Sales by Application (2015 and 2016)
Table France Sorafenib Market Share by Application (2015 and 2016)
Figure UK Sorafenib Sales and Growth Rate (2012-2017)
Figure UK Sorafenib Revenue and Growth Rate (2012-2017)
Figure UK Sorafenib Sales Price Trend (2012-2017)
Table UK Sorafenib Sales by Manufacturers (2015 and 2016)
Table UK Sorafenib Market Share by Manufacturers (2015 and 2016)
Table UK Sorafenib Sales by Type (2015 and 2016)
Table UK Sorafenib Market Share by Type (2015 and 2016)
Table UK Sorafenib Sales by Application (2015 and 2016)
Table UK Sorafenib Market Share by Application (2015 and 2016)
Figure Russia Sorafenib Sales and Growth Rate (2012-2017)
Figure Russia Sorafenib Revenue and Growth Rate (2012-2017)
Figure Russia Sorafenib Sales Price Trend (2012-2017)
Table Russia Sorafenib Sales by Manufacturers (2015 and 2016)
Table Russia Sorafenib Market Share by Manufacturers (2015 and 2016)
Table Russia Sorafenib Sales by Type (2015 and 2016)
Table Russia Sorafenib Market Share by Type (2015 and 2016)
Table Russia Sorafenib Sales by Application (2015 and 2016)
Table Russia Sorafenib Market Share by Application (2015 and 2016)
Figure Italy Sorafenib Sales and Growth Rate (2012-2017)
Figure Italy Sorafenib Revenue and Growth Rate (2012-2017)
Figure Italy Sorafenib Sales Price Trend (2012-2017)
Table Italy Sorafenib Sales by Manufacturers (2015 and 2016)
Table Italy Sorafenib Market Share by Manufacturers (2015 and 2016)
Table Italy Sorafenib Sales by Type (2015 and 2016)
Table Italy Sorafenib Market Share by Type (2015 and 2016)
Table Italy Sorafenib Sales by Application (2015 and 2016)
Table Italy Sorafenib Market Share by Application (2015 and 2016)
Figure Spain Sorafenib Sales and Growth Rate (2012-2017)
Figure Spain Sorafenib Revenue and Growth Rate (2012-2017)
Figure Spain Sorafenib Sales Price Trend (2012-2017)
Table Spain Sorafenib Sales by Manufacturers (2015 and 2016)
Table Spain Sorafenib Market Share by Manufacturers (2015 and 2016)
Table Spain Sorafenib Sales by Type (2015 and 2016)
Table Spain Sorafenib Market Share by Type (2015 and 2016)
Table Spain Sorafenib Sales by Application (2015 and 2016)
Table Spain Sorafenib Market Share by Application (2015 and 2016)
Figure Benelux Sorafenib Sales and Growth Rate (2012-2017)
Figure Benelux Sorafenib Revenue and Growth Rate (2012-2017)
Figure Benelux Sorafenib Sales Price Trend (2012-2017)
Table Benelux Sorafenib Sales by Manufacturers (2015 and 2016)
Table Benelux Sorafenib Market Share by Manufacturers (2015 and 2016)
Table Benelux Sorafenib Sales by Type (2015 and 2016)
Table Benelux Sorafenib Market Share by Type (2015 and 2016)
Table Benelux Sorafenib Sales by Application (2015 and 2016)
Table Benelux Sorafenib Market Share by Application (2015 and 2016)
Table Pfizer Basic Information List
Table Pfizer Sorafenib Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Sorafenib Sales Market Share (2012-2017)
Table Allergan Basic Information List
Table Allergan Sorafenib Sales, Revenue, Price and Gross Margin (2012-2017)
Table Allergan Sorafenib Sales Market Share (2012-2017)
Table Alnylam Pharmaceuticals Basic Information List
Table Alnylam Pharmaceuticals Sorafenib Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Alnylam Pharmaceuticals Sorafenib Sales Market Share (2012-2017)
Table Amgen Basic Information List
Table Amgen Sorafenib Sales, Revenue, Price and Gross Margin (2012-2017)
Table Amgen Sorafenib Sales Market Share (2012-2017)
Table Angstrom Pharmaceuticals Basic Information List
Table Angstrom Pharmaceuticals Sorafenib Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Angstrom Pharmaceuticals Sorafenib Sales Market Share (2012-2017)
Table Acceleron Pharma Basic Information List
Table Acceleron Pharma Sorafenib Sales, Revenue, Price and Gross Margin (2012-2017)
Table Acceleron Pharma Sorafenib Sales Market Share (2012-2017)
Table Biocon Basic Information List
Table Biocon Sorafenib Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Biocon Sorafenib Sales Market Share (2012-2017)
Table Bionomics Basic Information List
Table Bionomics Sorafenib Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bionomics Sorafenib Sales Market Share (2012-2017)
Table CASI Pharmaceuticals Basic Information List
Table CASI Pharmaceuticals Sorafenib Sales, Revenue, Price and Gross Margin (2012-2017)
Figure CASI Pharmaceuticals Sorafenib Sales Market Share (2012-2017).
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Sorafenib
Figure Manufacturing Process Analysis of Sorafenib
Figure Sorafenib Industrial Chain Analysis
Table Raw Materials Sources of Sorafenib Major Manufacturers in 2016
Table Major Buyers of Sorafenib
Table Distributors/Traders List
Figure Germany Sorafenib Sales and Growth Rate Forecast (2017-2022)
Figure Germany Sorafenib Revenue and Growth Rate Forecast (2017-2022)
Figure France Sorafenib Sales and Growth Rate Forecast (2017-2022)
Figure France Sorafenib Revenue and Growth Rate Forecast (2017-2022)
Figure UK Sorafenib Sales and Growth Rate Forecast (2017-2022)
Figure UK Sorafenib Revenue and Growth Rate Forecast (2017-2022)
Figure Russia Sorafenib Sales and Growth Rate Forecast (2017-2022)
Figure Russia Sorafenib Revenue and Growth Rate Forecast (2017-2022)
Figure Italy Sorafenib Sales and Growth Rate Forecast (2017-2022)
Figure Italy Sorafenib Revenue and Growth Rate Forecast (2017-2022)
Figure Spain Sorafenib Sales and Growth Rate Forecast (2017-2022)
Figure Spain Sorafenib Revenue and Growth Rate Forecast (2017-2022)
Figure Benelux Sorafenib Sales and Growth Rate Forecast (2017-2022)
Figure Benelux Sorafenib Revenue and Growth Rate Forecast (2017-2022)
Table Europe Sorafenib Sales Forecast by Type (2017-2022)
Table Europe Sorafenib Sales Forecast by Application (2017-2022)

COMPANIES MENTIONED

Pfizer
Allergan
Alnylam Pharmaceuticals
Amgen
Angstrom Pharmaceuticals
Acceleron Pharma
Biocon
Bionomics
CASI Pharmaceuticals
Celgene Corporation
Enzon Pharmaceuticals
Five Prime Therapeutics
Fujifilm Kyowa Kirin Biologics
Genentech
Genexine
Hetero Drugs
ImClone Systems
Intas Pharmaceuticals
Kyowa Hakko Kirin
Levolta Pharmaceuticals
Mabtech
Marsala Biotech
Neumedicines
Novartis
Oncobiologics
Onyx Pharmaceuticals